194 related articles for article (PubMed ID: 9264371)
1. Deletion of chromosome arm 3p in hematologic malignancies.
Johansson B; Billström R; Kristoffersson U; Akerman M; Garwicz S; Ahlgren T; Malm C; Mitelman F
Leukemia; 1997 Aug; 11(8):1207-13. PubMed ID: 9264371
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic polyclonality in hematologic malignancies.
Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
Johansson B; Mertens F; Mitelman F
Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
[TBL] [Abstract][Full Text] [Related]
5. Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms.
Knuutila S; Teerenhovi L; Larramendy ML; Elonen E; Franssila KO; Nylund SJ; Timonen T; Heinonen K; Mahlamäki E; Winqvist R
Genes Chromosomes Cancer; 1994 Jun; 10(2):95-102. PubMed ID: 7520272
[TBL] [Abstract][Full Text] [Related]
6. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
8. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.
Sato Y; Suto Y; Pietenpol J; Golub TR; Gilliland DG; Davis EM; Le Beau MM; Roberts JM; Vogelstein B; Rowley JD
Blood; 1995 Aug; 86(4):1525-33. PubMed ID: 7632960
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
10. Geographic heterogeneity of neoplasia-associated chromosome aberrations.
Johansson B; Mertens F; Mitelman F
Genes Chromosomes Cancer; 1991 Jan; 3(1):1-7. PubMed ID: 2069905
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.
Neuman WL; Rubin CM; Rios RB; Larson RA; Le Beau MM; Rowley JD; Vardiman JW; Schwartz JL; Farber RA
Blood; 1992 Mar; 79(6):1501-10. PubMed ID: 1347709
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
Zhang LJ; Shin ES; Yu ZX; Li SB
Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetically unrelated clones in hematological neoplasms.
Heim S; Mitelman F
Leukemia; 1989 Jan; 3(1):6-8. PubMed ID: 2909809
[TBL] [Abstract][Full Text] [Related]
15. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
16. Deletions and rearrangement of CDKN2 in lymphoid malignancy.
Stranks G; Height SE; Mitchell P; Jadayel D; Yuille MA; De Lord C; Clutterbuck RD; Treleaven JG; Powles RL; Nacheva E
Blood; 1995 Feb; 85(4):893-901. PubMed ID: 7849311
[TBL] [Abstract][Full Text] [Related]
17. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic analysis of hematologic malignancies in Hong Kong. A study of 98 cases.
Chan LC; Kwong YL; Liu HW; Chan TK; Todd D; Ching LM
Cancer Genet Cytogenet; 1992 Sep; 62(2):154-9. PubMed ID: 1394102
[TBL] [Abstract][Full Text] [Related]
19. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. The Czechoslovak MDS Cooperative Group.
Michalová K; Musilová J; Zemanová Z
Czech Med; 1990; 13(4):133-44. PubMed ID: 2081440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]